The Cleveland Clinic’s fourth annual Alzheimer disease (AD) drug development pipeline presents a new round of clinical trials to give clinicians a comprehensive look at current research in the US. The investigators, led by Jeffrey Cummings, MD, ScD, director emeritus of Cleveland Clinic Lou Ruvo Center for Brain Health, identified all pharmacologic Alzheimer trials currently in development from Clinicaltrials.gov. They found 132 agents currently in 156 clinical trials— 28 of which are in 42 phase 3 trials; 74 in 83 phase 2 trials; and 30 in 31 phase 1 trials.

A series of studies led by the University of Nevada, Las Vegas said regular slot players can’t tell the difference between the house edge from one game to another.

On the list of top 10 complaints parents have to listen to, "I don't want to go to school today" probably ranks right up there with "He's bugging me" and "I just want to text my friends!"

At the 2019 American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania, Jeffrey Cummings, MD, ScD, director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health and vice chair for department of brain health at the University of Nevada Las Vegas, spoke with NeurologyLive in an interview to discuss several hot topics in Alzheimer disease.

The grasshopper invasion of the Las Vegas Valley is well underway.

A grasshopper swarm in the Las Vegas Valley of Nevada has been so thick at times that the National Weather Service warned motorists it could impact visibility on area roads.

Children whose parents have lower levels of education have a significantly higher risk of dying young, according to a new study by researchers at UNLV.

A series of studies led by UNLV researchers says regular slot players can’t tell the difference between the house edge from one game to another.